Table 1.
Characteristic | Group I (n = 23) | Group II (n = 18) |
---|---|---|
Age in years, median ± QR (min; max) | 63·0 ± 12·0 (21; 76) | 67·5 ± 19·5 (46; 82) |
Gender, n (%) | ||
Males | 12 (52·2) | 10 (55·6) |
Females | 11 (47·8) | 8 (44·4) |
Race, n (%) | ||
White | 15 (65·2) | 13 (72·2) |
Non white | 8 (34·8) | 5 (27·8) |
History of heart disease | 6 (26·1) | 3 (16·7) |
Diabetes mellitus, n (%) | ||
Type 1 | 2 (8·7) | 2 (11·1) |
Type 2 | 21 (91·3) | 16 (88·9) |
Time with diabetes in years | 20·1 ± 8·5 | 17·5 ± 10·1 |
Ulcer duration in months, median ± QR (min; max) | 1·0 ± 1·5 (0·3; 120) | 1·0 ± 1·5(0·4; 12) |
ABI > 0·8 | 7 (30·4%) | 4 (22·2%) |
ABI < 0·8 | ||
Femoral–popliteal | 7 (30·4%) | 1 (5·6%) |
Distal | 9 (39·1%) | 13 (72·2%) |
Ulcer size (cm2), median ± QR (min; max) | 22·5 ± 35·0 (6; 300) | 25·0 ± 10·9 (10; 110·5) |
Predominant aetiopathogenic feature, n (%) | ||
Neuropathic | 6 (26·1) | 8 (44·4) |
Ischaemic | 17 (74·9) | 10 (55·6) |
Wagner’s classification, n (%) | ||
Grade 3 | 18 (78·3) | 18 (100·0) |
Grade 4 | 5 (21·7) | 0 (0) |
Ulcer location, n (%) | ||
Toes | 15 (65·2) | 12 (66·7) |
Internal edge | 1 (4·3) | – |
External edge | 3 (13·0) | 4 (22·2) |
Dorsum | 4 (17·4) | 2 (11·1) |
Sole | 5 (21·7) | 4 (22·2) |
Transmetatarsal | 3 (13·0) | 2 (11·1) |
Ankle | 3 (13·0) | 2 (11·1) |
ABI, Ankle‐brachial index; QR, interquartile range.